methyl pyruvate has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inanami, O; Nagane, M; Nishida, N; Yamamori, T; Yasui, H | 1 |
1 other study(ies) available for methyl pyruvate and Lung Neoplasms
| Article | Year |
|---|---|
3-Methyl pyruvate enhances radiosensitivity through increasing mitochondria-derived reactive oxygen species in tumor cell lines.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Mitochondria; Pyruvates; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species | 2014 |